Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions
Pancreatic CancerMetastasisEpigenetic
Trial Locations (1)

Unknown

RECRUITING

A Beneficência Portuguesa de São Paulo, São Paulo

All Listed Sponsors
lead

Benedito Mauro Rossi

OTHER